Drugs Made In America Acquisition (DMAA) Long-Term Investments (2025)
Drugs Made In America Acquisition (DMAA) reported Long-Term Investments of $239.9 million for Q4 2025, up 0.97% quarter-over-quarter from $237.6 million in Q3 2025.
Drugs Made In America Acquisition (DMAA) Long-Term Investments (2025) Analysis & Trends
Drugs Made In America Acquisition has reported Long-Term Investments for 1 years, with the latest figure at $239.9 million in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Investments changed N/A year-over-year to $239.9 million; the trailing twelve-month figure through Dec 2025 stood at $239.9 million (changed N/A YoY), and the FY2025 full-year result was $239.9 million, changed N/A from the prior year.
- Long-Term Investments for Q4 2025 stood at $239.9 million, up from $237.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $239.9 million in Q4 2025, with the low at $232.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 472.82 Mn |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | 311.36 Mn |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 310.90 Mn |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 309.18 Mn |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 310.26 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 307.78 Mn |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 271.71 Mn |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 259.89 Mn |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | 43,750.00 |
| 10 | Drugs Made In America Acquisition | 223.11 Mn | 223.11 Mn | - | 239.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 239.91 Mn |
| Sep 30, 2025 | 237.60 Mn |
| Jun 30, 2025 | 235.16 Mn |
| Mar 31, 2025 | 232.74 Mn |